Biotechnology experts from the International Science and Technology Park of the Academy of Sciences of Turkmenistan have achieved a major breakthrough with the development of a new microencapsulation technology for the medicinal plant Alhagi (camelthorn). The State Intellectual Property Service of the Ministry of Finance and Economy of Turkmenistan has already certified this unique innovation, Turkmenistan’s official media reported on Friday.
With growing interest in local medicinal plants, the need for methods that preserve the physical and chemical properties of plant extracts has become essential. The Alhagi extract is produced using a specialized blend, and the microencapsulation process encloses its active components in microscopic capsules, which controls release and enhances efficacy.
These extracts can be utilized in both medical preparations and the food industry. Concentrated extracts demonstrate high pharmacological activity, good tolerance, and a low likelihood of side effects.
A key advantage of this technology is its combination of high therapeutic and preventive properties with low production costs. Products developed using this technology meet modern phytotherapy standards, are made exclusively from natural ingredients, and exhibit excellent biological stability.
Alhagi (Alhagi persarum) is renowned for its numerous medicinal properties, including treatments for colds, flu, sore throat, bronchitis, and cough. The implementation of this new technology is part of the State Program for the Comprehensive Development of Biotechnology in Turkmenistan for 2024-2028.
